This is a long and complicated topic, so I’ve hesitated to wade into it. But since my default setting is to be wary of new and improved and highly touted health related products, I never did buy into the craze
To be filed in the “First, Do No Harm” category… Eur J Health Econ. 2011 Jun 22. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Kooreman P, Baars EW Department of Economics, Tilburg University,
Per my previous post about the Medical Device Industry trying to quash new regulations, there is this story. A Houston Lawyer is suing a subsidiary of Johnson and Johnson over hip replacement prosthetic devices that were supposed to last 15
I’m starting to bore myself with reporting on the dangerous drugs that have been approved and set loose on the market, but here’s another one. Link below. Please wait to take any new drug for several years, 7 at least,
An article from the New York Times comparing cranberry juice versus months of low dose antibiotics. No surprise that the antibiotic helped keep the infections away to a larger degree, and also no surprise that it lead to E Coli
From today’s New York Times, an article looking at various conditions that, if mitigated, will help to avoid Alzheimer’s. I won’t copy much of the article.But the following I will file in the “I Did Not Know That” file,(in bold.)
From today’s New York Times, an article looking at various conditions that, if mitigated, will help to avoid Alzheimer’s. I won’t copy much of the article.But the following I will file in the “I Did Not Know That” file,(in bold.)
I somehow missed the latest in a series of much-hyped, best-selling drugs turning out to have major problems. This article was released over the July 4th holiday, so I didn’t notice it. Long story short, Chantix is still on the
UCSF, Stanford autism study shows surprises Erin Allday, Chronicle Staff Writer Tuesday, July 5, 2011 San Francisco — Environmental factors play a more important role in causing autism than previously assumed and, surprisingly, an even larger role than genetics, according
From the New York Times. A few of my other posts on conflicts of interest in corporate research here, here,and here.Spine Experts Repudiate Medtronic StudiesBy BARRY MEIER and DUFF WILSON In an extraordinary move, a group of spine specialists are
